Natalia Kunst

Image of Natalia Kunst
Norwegian version of this page
Email natalia.kunst@medisin.uio.no
Username
Visiting address Forskningsveien 3A Harald Schjelderups hus 0373 Oslo
Postal address Postboks 1089 Blindern 0317 Oslo

Academic interests

Decision-analytic modeling, cost-effectiveness analyses, value of information (VOI), health economic evaluation, disease mathematical modeling, Bayesian methods and decision theory, causal inference

Courses Tought

  • Fall 2019 -  Teaching Fellow for the graduate-level course Cost-Effectiveness Analysis and Decision Making [HPM 570], Yale University School of Public Health, Course Faculty: A. David Paltiel
  • Spring 2019 - Teaching Fellow for Advanced Topics in Decision-making in Medicine [EWP02], Erasmus Medical Center, Course Faculty: Myriam Hunink

Background

  • 2019 – Postgraduate Research Fellow, Yale University School of Medicine

  • 2018 –   Visiting PhD Candidate, Public Health Modeling Unit Yale University School of Public Health

  • 2017 –   PhD Candidate in Health Decision Sciences, University of Oslo

  • 2017 –   PhD Research Fellow, Decision Modeling Center VUmc Amsterdam

  • 2015 –   Senior Health Economist, LINK Medical Research

  • PhD courses and research activities, Department of Economics, Gdansk University of Technology, 2011-2013  

  • MSc, Department of Economics, Gdansk University of Technology, 2011

  • MSc, Department of Economics and Economic Policy, Gdynia University, 2011

Awards

  • Gold medal for outstanding academic results and scientific research during the master’s program from the Rector of Gdansk University of Technology.
  • Award for the best master’s thesis in Labor Economics organized by the Regional Labor Office in Gdansk.

Collaboration

 

Tags: Health economics, Economic evaluation

Publications

  • Tuffaha, Haitham; Rothery, Claire; Kunst, Natalia; Jackson, Chris; Strong, Mark & Birch, Stephen (2021). A Review of Web-Based Tools for Value-of-Information Analysis. Applied Health Economics and Health Policy. ISSN 1175-5652. 19(5), p. 645–651. doi: 10.1007/s40258-021-00662-4.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Lindau, Stacy T. [Show all 8 contributors for this article] (2021). Understanding Regional Variation in the Cost of Breast Cancer Screening among Privately Insured Women in the United States. Medical Care. ISSN 0025-7079. 59(5), p. 437–443. doi: 10.1097/MLR.0000000000001506.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Show all 7 contributors for this article] (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2(HER2)–Positive Breast Cancer. JAMA Network Open. ISSN 2574-3805. doi: 10.1001/jamanetworkopen.2020.27074.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle; Schrag, Deborah & Kuntz, Karen (2020). Estimating population-based recurrence rates of colorectal cancer over time in the United States. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 29(12), p. 2710–2718. doi: 10.1158/1055-9965.EPI-20-0490.
  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. PharmacoEconomics (Auckland). ISSN 1170-7690. doi: 10.1007/s40273-020-00942-2.
  • Kunst, Natalia; Wilson, Edward C.F.; Glynn, David; Alarid-Escudero, Fernando; Baio, Gianluca & Brennan, Alan [Show all 14 contributors for this article] (2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health. ISSN 1098-3015. 23(6), p. 734–742. doi: 10.1016/j.jval.2020.02.010.
  • Heath, Anna; Kunst, Natalia; Jackson, Christopher; Strong, Mark; Alarid-Escudero, Fernando & Goldhaber-Fiebert, Jeremy D. [Show all 9 contributors for this article] (2020). Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Medical decision making. ISSN 0272-989X. doi: 10.1177/0272989X20912402.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Show all 7 contributors for this article] (2020). Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.0262.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando; Paltiel, A. David & Wang, Shi-Yi (2019). A value of information analysis of research on the 21-gene assay for breast cancer management. Value in Health. ISSN 1098-3015. 22(10), p. 1102–1110. doi: 10.1016/j.jval.2019.05.004.
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2019). Cost-effectiveness of diagnostic algorithms for peanut allergy in children. Journal of Allergy and Clinical Immunology. ISSN 0091-6749. 143(3), p. 1243–1246. doi: 10.1016/j.jaci.2018.10.050.

View all works in Cristin

  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018 (PharmacoEconomics, (2020), 38, 10, (1135-1145), 10.1007/s40273-020-00942-2). PharmacoEconomics (Auckland). ISSN 1170-7690. 38(12). doi: 10.1007/s40273-020-00968-6.
  • Byrne, Jennifer & Kunst, Natalia (2020). Mammography for women aged 40 to 49 years associated with high, widely variable costs. [Internet]. Healio.
  • Kunst, Natalia & Mamoun, Fred (2020). Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s. [Internet]. Yale News.
  • Dunleavy, Brian P. & Kunst, Natalia (2020). Less than half of women in their 40s screened for breast cancer each year. [Internet]. United Press International.
  • Kunst, Natalia (2020). Quantifying the value of further research to improve 21-gene assay decision-making in breast cancer.
  • Kunst, Natalia (2020). Value of Information analysis in medical decision making.
  • Kunst, Natalia & Gross, Cary (2020). Breast Cancer Screening and Health Care Costs—Reply. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.2355.
  • Furlow, Bryant & Kunst, Natalia (2019). All Women with Breast Cancer Should Undergo Multigene Testing, Study Suggests. [Journal]. Cancer Network.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Show all 7 contributors for this article] (2019). Cost-effectiveness of different neoadjuvant followed by adjuvant treatment strategies for women with HER2-positive breast cancer (Spotlight Session).
  • Kunst, Natalia (2019). Finding the optimal diagnostic algorithm for children with peanut allergy: A cost-effectiveness study.
  • Kunst, Natalia (2019). Diagnosing peanut allergy in children: A cost-effectiveness analysis of diagnostic algorithms.
  • Kunst, Natalia; Grosse, Scott; Chen, Yao-Hsuan; Kim, David & Wisløff, Torbjørn (2019). Overview of various recommendations for health economic perspective. Symposium: Value for whom? Choice and Consequences of Perspective in Economic Evaluations.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Show all 7 contributors for this article] (2019). Utilization and costs of breast cancer screening for women in their 40s in a privately insured US population.
  • Kunst, Natalia; Wilson, Ed; Alarid-Escudero, Fernando; Baio, Gianluca; Brennan, Alan & Fairley, Michael [Show all 14 contributors for this article] (2019). Practical Considerations for the Efficient Computation of the Expected Value of Sample Information to Prioritize Research in Health Care.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle & Kuntz, Karen (2019). Real-World Recurrence Rates of Colorectal Cancer over Time.
  • Kunst, Natalia R. (2019). A comprehensive value of information analysis to assess the state of the evidence and quantify uncertainty on the use of 21-gene assay Oncotype DX.
  • Kunst, Natalia R. (2018). Future research on the 21-gene assay for breast cancer: A value of information analysis.
  • Kunst, Natalia R. (2018). What is the value of further research on the 21-gene assay for breast cancer management?
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2018). Diagnosing Peanut Allergy in Children: A Cost-Effectiveness Analysis of Diagnostic Algorithms.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando & Wang, Shi-Yi (2018). Decisions on Further Research for 21-Gene Assay in Real-World Management of Breast Cancer: A Value of Information Analysis. [Lee B. Lusted Award Finalist].
  • Kunst, Natalia R. (2017). Health economic modeling to determine the optimal diagnostic algorithm for nut allergy.

View all works in Cristin

Published Jan. 4, 2018 2:03 PM - Last modified Aug. 25, 2021 9:47 AM

Research groups